NASDAQ: SGMT Sagimet Biosciences Inc. 8-K

Sagimet grants CEO 300k stock options and 300k performance RSUs tied to regulatory milestones

Filed June 3, 2026 · Period ending May 28, 2026 · ~1 min read

4 material changes detected in this filing.

Create a free account to read the full summary — it takes 30 seconds.

Partner

Trade SGMT commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Generated by AI · Jun 4, 2026 3:48 PM